Lucy Day

Insider Reports History

Entity
Individual
Location
2032 Middlefield Road, Palo Alto, CA
Signature
/s/ Lucy Day
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lucy Day:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Financial Officer Common Stock 30.6K $585K $19.11 Mar 15, 2024 Direct
AN2 Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 55K Mar 15, 2024 Direct

Insider Reports Filed by Lucy Day

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 1 $0 4/A Mar 29, 2024 Chief Financial Officer
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 18, 2024 Chief Financial Officer
ANTX AN2 Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Financial Officer
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Chief Financial Officer
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Chief Financial Officer